JG
CTIC

Jefferies Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Jefferies Group’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25,800
Closed -$101K – 2919
2018
Q1 		$101K Buy
+25,800
New +$90.7K ﹤0.01% 2060
2013
Q3 		– Sell
-1,147
Closed -$12K – 2449
2013
Q2 		$12K Buy
+1,147
New +$13.4K ﹤0.01% 1754

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Jefferies Group's CTIC Position: Q2 2018 in Review

Jefferies Group sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2018, closing a stake of 25,800 shares — an estimated $101K sold.

Jefferies Group first reported a position in CTIC in Q2 2013 and held it in 2 quarters. The position peaked at $101K in Q1 2018. 83 funds tracked by Wall St. Rank hold CTIC as of Q2 2018.

  • Jefferies Group reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2018 after selling out during the quarter.
  • Jefferies Group sold 25,800 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2018, an estimated $101K.
  • Jefferies Group first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 2 quarters.
  • Jefferies Group's CTI BioPharma Corp. (DE) Common Stock position peaked at $101K in Q1 2018.
  • 83 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2018.

Based on Jefferies Group's 13F filing for Q2 2018, filed 14 Aug 2018.